Over a quarter of stem cell transplant survivors develop cutaneous malignant neoplasms
Source: Healio, February 2025
More than one-quarter of blood or marrow transplant survivors developed cutaneous malignant neoplasms, according to study results.
Researchers identified several risk factors, including older age, development of chronic graft-versus-host disease and receipt of total body irradiation.
“This study demonstrated that certain people who undergo blood or marrow transplant are at greater risk for subsequent skin cancers based on their individual characteristics and the treatments they have received,” Kristy K. Broman, MD, MPH, assistant professor in the division of surgical oncology at The University of Alabama at Birmingham, told Healio. “These individuals should be followed more closely with routine exams by a dermatologist in order to detect and treat skin cancers at an early stage.”